GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

DuoGenic StemCells 7607.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

11.80

-1.26%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2024

Revenue

TWD 12.1m

FY2021FY2024

Net income

−TWD 61.6m

FY2021FY2024

Free cash flow

−TWD 48.5m

FY2021FY2024

Shareholders' equity

TWD 16.8m

FY2021FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021
RevenueTWD 12.1mTWD 13.7mTWD 6.9mTWD 2.3m
Gross profitTWD 4.1mTWD 4.9mTWD 2.3m−TWD 3.2m
Research and developmentTWD 24.3mTWD 14.3mTWD 13.7mTWD 10.3m
Operating income−TWD 61.0m−TWD 44.9m−TWD 33.4m−TWD 23.1m
Net income−TWD 61.6m−TWD 45.2m−TWD 34.0m−TWD 22.0m
Diluted earnings per share-2.02-1.50-1.11-0.72

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021
Total assetsTWD 59.7mTWD 94.0mTWD 82.2mTWD 74.1m
Cash and short-term investmentsTWD 25.1mTWD 46.3mTWD 42.8mTWD 51.4m
Total liabilitiesTWD 42.8mTWD 15.6mTWD 8.6mTWD 4.4m
DebtTWD 35.8mTWD 7.2mTWD 2.7mTWD 1.6m
Shareholders' equityTWD 16.8mTWD 78.4mTWD 73.6mTWD 69.7m
Shares outstanding31m30m31m31m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021
Cash from operations−TWD 47.3m−TWD 43.7m−TWD 33.4m−TWD 20.0m
Capital spending−TWD 1.2m−TWD 1.0m−TWD 12.0m−TWD 9.0m
Free cash flow−TWD 48.5m−TWD 44.7m−TWD 45.4m−TWD 29.0m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023
RevenueTWD 10.4mTWD 7.0mTWD 5.1mTWD 6.4mTWD 7.3m
Gross profitTWD 8.2mTWD 3.2mTWD 944,000TWD 2.1mTWD 2.8m
Operating income−TWD 13.7m−TWD 28.3m−TWD 32.7m−TWD 23.0m−TWD 21.8m
Net income−TWD 14.4m−TWD 29.3m−TWD 32.3m−TWD 23.3m−TWD 22.0m
Diluted earnings per share-0.47-0.96-1.06-0.76-0.73
Total assetsTWD 57.7mTWD 59.7mTWD 59.8mTWD 94.0mTWD 113.2m
Cash and short-term investmentsTWD 30.9mTWD 25.1mTWD 20.3mTWD 46.3mTWD 69.3m
DebtTWD 31.6mTWD 33.8mTWD 4.7mTWD 5.2mTWD 3.9m
Shareholders' equityTWD 18.4mTWD 16.8mTWD 46.1mTWD 78.4mTWD 101.7m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue73.8%——
Operating income38.1%——
Net income41.0%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin35.0%23.3%——

Valuation history

At each fiscal year end

FY2024FY2023
Price to earnings-11.5-24.1
Price to sales58.679.7

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.